Komiya T, Shike T, Mori H, Santo M L, Suda K, Kondo T, Mizuno Y
Department of Neurology, Juntendo University School of Medicine, Tokyo, Japan.
No To Shinkei. 1994 Sep;46(9):895-904.
We report a 54-year-old man with progressive generalized muscle atrophy and ophthalmoparesis in the terminal stage. He was well until 44 years of age (1982) when he noted weakness in his right hand and muscle atrophy; in May of 1985, he noted weakness in his left hand and in both legs. His weakness had become progressively worse, and he became unable to walk in November of 1985. He noted dysarthria one month later, and dysphagia in March of 1986. His difficulty in swallowing had also become worse; he regurgitated foods into the trachea in September of that year, and he developed a low grade fever on the same day. He was admitted to our service on September 24, 1987. On physical examination, general findings were unremarkable, except for low grade fever (37.3 degrees C). On neurologic examination, he was alert and mentally sound. He had normal vision and visual fields; ocular movements were normal. He had moderate weakness in facial muscles, dysarthria, dysphagia, and atrophy in his tongue. He had marked generalized muscle atrophy with fasciculation. He was unable to stand or walk. His muscle strength was not more than 1/6 in any part. The lower extremities were spastic. Deep reflexes were exaggerated in both lower extremities but were normal in upper extremities. Sensation was intact. Laboratory examination was unremarkable, and so was the cranial CT scan. He was treated with nasogastric feeding. He was able to communicate smoothly using his eyes, but a restriction in the vertical gaze was noted in February of 1989. The range of ocular movement was better in the oculocephalic reflex compared with his spontaneous vertical eye movements. In April of 1990, his horizontal gaze also had become slow, and he was complicated by bronchial asthma. He was treated with 20 mg/day of prednisolone; after the institution of prednisolone, his horizontal eye movement showed much improvement. In the terminal stage, he was able to move his eyes only very slowly; vertical gaze was impossible. His subsequent course was complicated by respiratory tract infection and septicemia, and he expired on July 15, 1992. The patient was discussed in a neurological CPC, and the chief discussant arrived at the conclusion that this patient had amyotrophic lateral sclerosis with oculomotor paresis. Post-mortem examination revealed spongy change involving the posterior column and the posterior spinocerebellar tract, in addition to severe degenerative change in the upper and the lower motoneurons, which were consistent with amyotrophic lateral sclerosis.(ABSTRACT TRUNCATED AT 400 WORDS)
我们报告一名54岁男性,处于疾病终末期,有进行性全身肌肉萎缩和眼肌麻痹。他一直健康,直到44岁(1982年)时发现右手无力和肌肉萎缩;1985年5月,他注意到左手和双腿也出现无力。他的无力症状逐渐加重,1985年11月已无法行走。一个月后出现构音障碍,1986年3月出现吞咽困难。他的吞咽困难也日益加重;同年9月食物反流至气管,并于同日出现低热。1987年9月24日入院。体格检查时,除低热(37.3℃)外,一般检查无异常。神经系统检查显示,他意识清醒、精神正常。视力和视野正常;眼球运动正常。面部肌肉有中度无力、构音障碍、吞咽困难,舌肌萎缩。全身有明显的肌肉萎缩并伴有肌束震颤。他无法站立或行走。任何部位的肌力均不超过1/6。下肢呈痉挛性。双下肢深反射亢进,但上肢正常。感觉正常。实验室检查无异常,头颅CT扫描也无异常。给予鼻饲治疗。他能用眼睛顺利交流,但1989年2月发现垂直凝视受限。与自发垂直眼球运动相比,眼头反射时眼球运动范围较好。1990年4月,他的水平凝视也变得缓慢,并并发支气管哮喘。给予泼尼松龙20mg/天治疗;使用泼尼松龙后,他的水平眼球运动有明显改善。在疾病终末期,他只能非常缓慢地移动眼睛;无法进行垂直凝视。随后他并发呼吸道感染和败血症,于1992年7月15日死亡。该病例在神经科临床病理讨论会上进行了讨论,主要讨论者得出结论,该患者患有伴有动眼神经麻痹的肌萎缩侧索硬化症。尸检显示,除上下运动神经元严重变性外,后索和脊髓后小脑束有海绵状改变,这与肌萎缩侧索硬化症相符。(摘要截选至400字)